| Title： | Clinical application guideline for the use of integrated Chinese and Western therapy in prevention and treatment of chronic obstructive pulmonary disease |
| Edition： | Original |
| Classification： | Traditional Chinese Medicine guideline |
| Field： | Treatment |
| Countries and regions： | China |
| Guidelines users： | TCM practitioner, integrated Chinese and western Medicine physician, and western medicine physician. |
| Evidence classification method： | GRADE methods |
| Development unit： | The First Affiliated Hospital of Anhui University of Chinese Medicine；West China Hospital of Sichuan University |
| Registration time: | 2024-03-06 |
| Registration number： | PREPARE-2023CN387 |
| Purpose of the guideline: | This guide aims to use the combination of traditional Chinese medicine (TCM) and Western medicine as an intervention method for addressing critical clinical issues in the prevention and treatment of chronic obstructive pulmonary disease (COPD). It clearly defines the target population for TCM interventions in COPD, identifies the key points and timing for implementing a combination of TCM and Western medicine, and highlights the complementary advantages of integrating TCM and Western medicine. The guide focuses on the specific advantages of TCM and Western medicine in COPD prevention (including disease progression, exacerbation, deterioration, and recurrence), treatment (including symptom relief, reduction of acute exacerbations, and improvement of quality of life), and safety (including minimizing adverse reactions). It is of significant clinical importance for optimizing comprehensive management of COPD and improving prognosis for COPD patients. |
